A "sweetness crisis" triggered by the weight loss "miracle drug": Sugar prices halved, even Magnum isn't selling anymore!
GLP-1 weight loss drugs are shifting consumer preferences from “sweet” to “protein,” and this shift is rapidly affecting the valuations of commodities and consumer goods companies: sugar demand is being repriced, protein-related raw materials are strengthening, and high-sugar categories are facing structural pressure. On Wednesday, New York raw sugar futures